Table 2. Recommended minimal follow-up for seminoma clinical stage I on active surveillance.
Modality | Year 1 | Year 2 | Year 3 | Year 4&5 | After 5 years |
---|---|---|---|---|---|
Tumour markers and doctor visit | 2 times | 2 times | 2 times | Once | Further management According to survivorship care plan |
Chest X ray | – | – | – | – | |
Abdominopelvic computed tomography/Magnetic resonance imaging | 2 times | 2 times | Once at 36 months | Once at 60 months |
Note: From EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam 2022. ISBN 978-94-92671-16-5.